Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antibody-based immunological therapies

A M Scott1, S Welt

  • 1Ludwig Institute for Cancer Research, Melbourne Tumour Biology Branch, Austin, Australia. scott@licre.ludwig.edu.au

Current Opinion in Immunology
|November 22, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of Lean body mass using whole-body low-dose Ct from Pet/Ct to identify cancer Cachexia.

Cancer imaging : the official publication of the International Cancer Imaging Society·2026
Same author

Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [<sup>18</sup>F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors.

Cancer imaging : the official publication of the International Cancer Imaging Society·2022
Same author

Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [<sup>18</sup>F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0.

European journal of nuclear medicine and molecular imaging·2022
Same author

Prevalence of hypoxia and correlation with glycolytic metabolism and angiogenic biomarkers in metastatic colorectal carcinoma.

European journal of nuclear medicine and molecular imaging·2020
Same author

Does copper treatment of commonly touched surfaces reduce healthcare-acquired infections? A systematic review and meta-analysis.

The Journal of hospital infection·2020
Same author

Correction to: Nuclear medicine services after COVID-19: gearing up back to normality.

European journal of nuclear medicine and molecular imaging·2020
Same journal

A blind spot of human T cell immunology: epitope specificity in secondary lymphoid organs.

Current opinion in immunology·2026
Same journal

Germinal center responses at barrier organ sites.

Current opinion in immunology·2026
Same journal

Ocular sarcoidosis: from clinical signs to targeted interventions.

Current opinion in immunology·2026
Same journal

On or within: spatial determinants of antigen handling in the nasal turbinates.

Current opinion in immunology·2026
Same journal

Decoding the complexity of intestinal immunity with spatial transcriptomics.

Current opinion in immunology·2026
Same journal

Reconsidering the immunological aspects of solid-phase assays for antiphospholipid antibodies detection.

Current opinion in immunology·2026
See all related articles

Antibody-based tumor targeting shows promise for cancer therapy. Despite challenges in finding specific targets, recent trials demonstrate successful antibody therapy for lymphoma, colon, and breast cancers.

Area of Science:

  • Oncology
  • Immunotherapy
  • Molecular Biology

Background:

  • Antibody-based tumor-targeted therapy aims to selectively deliver drugs to cancer cells by targeting specific cell surface antigens.
  • Identifying antigens with restricted expression to tumors has been a significant challenge, limiting drug delivery efficiency.
  • Despite these challenges, advancements in understanding tumor biology have paved the way for progress.

Purpose of the Study:

  • To review the progress and challenges in antibody-based tumor-targeted therapy.
  • To highlight the successful application of antibody-based therapies in recent clinical trials.

Main Methods:

  • Review of clinical research and recent trial outcomes in antibody-based tumor-targeted therapy.
  • Analysis of the biological and physiological principles guiding antibody-drug delivery to tumors.

Related Experiment Videos

Main Results:

  • Few antibody-antigen systems have been identified for highly specific tumor targeting and effective drug delivery to metastatic cancer.
  • Recent clinical trials have shown successful antibody-based therapy outcomes for lymphoma, colon cancer, and breast cancer.

Conclusions:

  • While challenges in target identification persist, a deeper understanding of tumor biology is enabling effective antibody-based cancer therapies.
  • Antibody-targeted therapy represents a promising approach for treating various cancers, with ongoing research expected to yield further advancements.